Pharmacopeia's DARA Program For Hypertension And Diabetic Nephropathy Advances Into Phase 1 Clinical Trials
Thu, 15 Feb 2007 08:00 AM EST
... Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced the initiation of a Phase 1 clinical study of PS433540, the company's lead internal product candidate. [click link for full article] ...
Related Topics
- Clinical Trials
- Retinopathy
- Diabetic Foot
- Pulmonary Hypertension
- IgA Nephropathy
- Diabetic Diet
- Diabetic Neuropathy
- Intracranial Hypertension
- Hypertension
- Pharmacology
- Membranous Nephropathy
- Psychopharmacology
- Health psychology
- Neuropathy
- Analgesic Nephropathy: Painkillers and the Kidneys
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Clinical Growth Charts
- Diabetic Eye Problems
- Pediatric Aids

Not Signed In -


